Predicting AF Progression with a Personalized Heart Test Approach
Part of Heart & circulation clinical trials.
This study is testing whether a combination of heart tests can better predict how atrial fibrillation (AF) gets worse over time. It aims to create a personalized plan to manage your AF and improve treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a history of atrial fibrillation (AF) that comes and goes (paroxysmal) or stays for a while (persistent).
- Your doctor has recommended an AF ablation procedure (a heart treatment to fix abnormal rhythms) based on current heart guidelines.
- You must be 18 years or older.
- You must be willing to sign an informed consent form to join the study.
- You must be able to follow the study's instructions and schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This study uses a genetic test to identify who might develop atrial fibrillation (an irregular heartbeat) in the future. Researchers believe certain genetic patterns combined with health factors can help predict this condition early, which could lead to better prevention.
This study looks at genetic factors in people with atrial fibrillation (an irregular heartbeat) and weak heart function to understand why some people's hearts recover after treatment and others don't. Researchers will collect blood samples and medical information to identify genetic patterns.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial uses an AI tool to analyze your heart's electrical signals (ECG) to better understand your risk of heart failure and how well your heart recovers after a procedure called catheter ablation for atrial fibrillation. It may help guide your treatment if you have early signs of heart failure.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.